Crinetics Pharmaceuticals
CRNX • NASDAQ • Stock Fundamentals
Crinetics Pharmaceuticals is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO R. Scott Struthers, with a market cap of $3.5B.
Market Cap$3.5B
Employees210.0
CEOR. Scott Struthers
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 7, 2026 · 1 month 7 days agoQ1 2026
View reportNext EarningsAug 6, 2026 · in 2 monthsAfter Market Close · Q2 2026
Financials
Based on Q1 2026 filing
Crinetics Pharmaceuticals FAQ
Common questions about Crinetics Pharmaceuticals
Crinetics Pharmaceuticals (CRNX) has a market capitalization of $3.5B and trades on NASDAQ.
Crinetics Pharmaceuticals has approximately 210 employees.